ESC Premium Access

Impact of atrial fibrillation on the progression and outcomes of isolated mild functional tricuspid regurgitation

Congress Session

About the speaker

Doctor Soongu Kwak

Seoul National University Hospital, Seoul (Korea (Republic of))
0 follower

130 more presentations in this session

Clinical and echocardiographic characteristics associated with the development of infective endocarditis in patients with significant mitral stenosis

Speaker: Doctor N. Ngiam (Singapore, SG)

Thumbnail

Local or general anesthesia for TAVI surgery? An updated systematic review and meta-analysis.

Speaker: Doctor Z. Cheng (Chengdu, CN)

Thumbnail

Use of left ventricular support devices during transcatheter aortic valve replacement and balloon aortic valvuloplasty: a single center experience

Speaker: Doctor S. Mahmood (Detroit, US)

Thumbnail

Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis

Speaker: Doctor T. Sugimoto (Tsu, JP)

Thumbnail

Impact of mitral valve regurgitation severity on clinical outcomes in patients with severe aortic stenosis undergoing TAVI

Speaker: Doctor V. Jimenez Franco (Madrid, ES)

Thumbnail

Access the full session

Valvular heart disease and infective endocarditis e-posters

Speakers: Doctor S. Kwak, Doctor N. Ngiam, Doctor Z. Cheng, Doctor S. Mahmood, Doctor T. Sugimoto...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Beta-blocker exposure and long-term survival in patients with transthyretin amyloid cardiomyopathy.

27 August 2021

ESC Premium Access

Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients: a subgroup analysis of age

27 August 2021

ESC Premium Access

Efficacy and safety of direct oral anticoagulants with diabetes and nonvalvular atrial fibrillation: a systematic review and meta-analysis

27 August 2021

This platform is supported by

logo Novo Nordisk